Jay Sutaria's personal training business is partnering with NASA to provide clients training fit for an astronaut. Blake Hobson/ST&F

Not everyone one can be an astronaut, but you might get to use their equipment. Sutaria Training & Fitness LLC, a Houston-based personal training company, is teaming up with one of the leading biomechanics that contracts with NASA that aims to provide exclusive access to astronaut training equipment to clients.

Jay Sutaria, founder and lead trainer, says that the equipment at NASA, called the force plate, shows how much power a client's body is producing in specific areas and how that power drops over time. The data produced by these machines can help trainers customize and tweak workouts for each client to take training a step further.

The Advanced Resistive Exercise Device, or ARED, works with the force plates Sutaria uses, and according to NASA's website, ARED includes force sensors located in the platform that are able to record force in three dimensions.

Sutaria and his contact at NASA recently tested the equipment with the Chinese olympic boxing team to see how it can be applied to workouts at NASA's location in Clear Lake.

"It's exclusive access to the equipment that is not available openly in Houston," said Sutaria. "NASA is a reference for us to become better trainers."

Sutaria founded his company in 2011 while he was a student at the University of Houston, and the company now operates with two trainers. His clients include professional athletes such as D.J. Augustin (Orlando Magic, NBA); and Tim Frazier (New Orleans Pelicans, NBA), however, Sutaria and his team offer professional personal training services to any type of athlete.

He says that his passion towards healing sports injuries stems from a back injury he suffered from throughout high school that greatly affected his performance. Sutaria had gone to physical therapy to repair the injury, but was trained incorrectly, which lead to more pain. After studying kinesiology and exercise science, he was able to fix his own chronic pain and help others like him.

"When I went into college with this physical therapy mindset, I wanted to help people get out of pain," Sutaria said.

In addition to his degree, Sutaria and all of the trainers on his team have diplomas from the National Personal Training Institute. Sutaria says that the trainers approach is data and science driven, focusing on a series of fundamental exercise movement and coaching.

"We've already helped hundreds of people, if you can help one person it's good for your community," said Sutaria.

ST&F is working to strengthen corporate partnerships, where the personal training company would offer mobility stretching training and nutritional guidance. He wants to open a gym this year; the company currently offers services out of Next Level Fitness in West University. The new gym will likely contain special equipment used at NASA, taking the collaboration even further. For now, clients that are interested in testing the equipment will have to travel to Clear Lake.

In addition to the permanent location, services are available in the Bellaire, River Oaks, Galleria, Heights, Sugar Land, Spring, Midtown, and Downtown neighborhoods, according to the website, and while Sutaria isn't writing off plans to expand to other cities, the company will remain focused on Houston for now.

Houston-based Kanthaka is the Uber or Lyft of personal training, and has recently expanded into the Austin market. Courtesy of Kanthaka

Get on-demand personal training from Houston-based app

Fitting in fitness

As a busy lawyer who traveled heavily for work, Sylvia Kampshoff found her workouts were often overlooked as she went from city to city, a casualty of long hours and a busy schedule. And, even though she did have a membership to a national gym with privileges at any of its locations, she hated the feeling of always being sold something and disliked that both the trainers and managers she worked with took very little interest in her personal needs and fitness goals.

She wanted something that allowed her to exercise with someone on her own schedule, and with people who valued customer service. That's how the idea for Kanthaka was born.

The app uses location technology similar to that of ride sharing apps to allow users to book training sessions with certified personal trainers, all of whom are heavily vetted and background checked by Kampshoff and her team.

"Many trainers at gyms or who work privately aren't certified," she says. "And that was important to me, that we have professionals who understand training and the body. And making sure our clients felt safe was a huge priority for me. We interview every trainer personally to ensure they not only meet our standards but also share our goals."

App users can select a trainer who will lead them in a Pilates, yoga, boxing, general training, or a pre- or post-natal workout. They select their location, as well as the date and they want to schedule a session. They can book a single session for $42 for a 45-minute session or $50 for an hour session or purchase a package of six or 12 workouts. There's no long-term commitment — although Kampshoff says that some clients are asking for a monthly subscription option — and the process is designed to be easy and user friendly. Trainers will arrive at a client's home, office, or their preferred gym, providing the gym allows outside trainers to work there.

The app launched in Houston in 2017 and then in Austin this fall. Over the last year, Kampshoff — who left the legal profession to concentrate on Kanthaka's success — says she's learned a lot about the market and her own preconceptions.

"I figured it was going to be business travelers who used it, people who were like me when I was doing all that travel," she says. "But it turns out that we're seeing people use it who want to schedule a session just like any other appointment. Many of our clients are women, who value the rigorous vetting process we have for our trainers."

In addition to vetting the trainers and confirming their certifications with the National Academy for Sports Medicine or the American Council on Exercise, each trainer is reviewed by app users, to help others determine whether that person would be a good fit for their needs. Kanthaka allows users to "favorite" trainers, and book them again, and user testimonials tout Kanthaka's easy of use and great training team.

In addition to individual users who find the app via social media or internet searches, Kampshoff has developed partnerships with hotels and apartments around Houston. Kanthaka provides personal training services to guests at the Post Oak Hotel, and Hanover apartment properties list the app as a feature for its residents.

As she continues to grow the business and expand in other cities, Kampshoff is excited to see others buying into her concept of fitness.

"There is a culture behind Kanthaka. It's about health and fitness, but also achieving the lifestyle you want that allows you to feel better and live in a more positive way."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.